26.04.2024 14:07:40 - dpa-AFX: *GILEAD SCIENCES: FDA APPROVES BIKTARVY(R) LABEL UPDATE WITH DATA FOR PREGNANT ADULTS WITH HIV

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Gilead Sciences 885823 NASDAQ 64,700 07.06.24 22:00:09 +0,850 +1,33% 64,620 64,700 63,820 63,850

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH